• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性癌症风险评估、咨询与检测的基本要素:美国国家遗传咨询师协会的更新建议

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.

作者信息

Riley Bronson D, Culver Julie O, Skrzynia Cécile, Senter Leigha A, Peters June A, Costalas Josephine W, Callif-Daley Faith, Grumet Sherry C, Hunt Katherine S, Nagy Rebecca S, McKinnon Wendy C, Petrucelli Nancie M, Bennett Robin L, Trepanier Angela M

机构信息

Southeast Nebraska Cancer Center, Lincoln, NE, USA.

出版信息

J Genet Couns. 2012 Apr;21(2):151-61. doi: 10.1007/s10897-011-9462-x. Epub 2011 Dec 2.

DOI:10.1007/s10897-011-9462-x
PMID:22134580
Abstract

Updated from their original publication in 2004, these cancer genetic counseling recommendations describe the medical, psychosocial, and ethical ramifications of counseling at-risk individuals through genetic cancer risk assessment with or without genetic testing. They were developed by members of the Practice Issues Subcommittee of the National Society of Genetic Counselors Familial Cancer Risk Counseling Special Interest Group. The information contained in this document is derived from extensive review of the current literature on cancer genetic risk assessment and counseling as well as the personal expertise of genetic counselors specializing in cancer genetics. The recommendations are intended to provide information about the process of genetic counseling and risk assessment for hereditary cancer disorders rather than specific information about individual syndromes. Essential components include the intake, cancer risk assessment, genetic testing for an inherited cancer syndrome, informed consent, disclosure of genetic test results, and psychosocial assessment. These recommendations should not be construed as dictating an exclusive course of management, nor does use of such recommendations guarantee a particular outcome. These recommendations do not displace a health care provider's professional judgment based on the clinical circumstances of a client.

摘要

这些癌症遗传咨询建议是在2004年首次发布的基础上更新而来,阐述了通过进行或不进行基因检测的癌症遗传风险评估,为高危个体提供咨询所涉及的医学、心理社会和伦理方面的影响。它们由美国国家遗传咨询师协会家族性癌症风险咨询特别兴趣小组实践问题小组委员会的成员制定。本文件中的信息来源于对当前关于癌症遗传风险评估和咨询的文献的广泛回顾,以及专门从事癌症遗传学的遗传咨询师的个人专业知识。这些建议旨在提供有关遗传性癌症疾病的遗传咨询和风险评估过程的信息,而非关于个别综合征的具体信息。基本组成部分包括接诊、癌症风险评估、遗传性癌症综合征的基因检测、知情同意、基因检测结果的披露以及心理社会评估。这些建议不应被理解为规定了唯一的管理方案,使用这些建议也不能保证特定的结果。这些建议并不取代医疗保健提供者基于客户临床情况的专业判断。

相似文献

1
Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.遗传性癌症风险评估、咨询与检测的基本要素:美国国家遗传咨询师协会的更新建议
J Genet Couns. 2012 Apr;21(2):151-61. doi: 10.1007/s10897-011-9462-x. Epub 2011 Dec 2.
2
Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.遗传性癌症风险评估与咨询:美国国家遗传咨询师协会的建议
J Genet Couns. 2004 Apr;13(2):83-114. doi: 10.1023/B:JOGC.0000018821.48330.77.
3
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.美国医学遗传学与基因组学学会及国家遗传咨询师协会的一份实践指南:癌症易感性评估的转诊指征
Genet Med. 2015 Jan;17(1):70-87. doi: 10.1038/gim.2014.147. Epub 2014 Nov 13.
4
Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors.遗传性乳腺癌和卵巢癌的风险评估与遗传咨询:美国国家遗传咨询师协会的建议
J Genet Couns. 2007 Jun;16(3):241-60. doi: 10.1007/s10897-007-9090-7. Epub 2007 May 17.
5
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
6
Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors.囊性纤维化携带者状态的分子检测实践指南:美国国家遗传咨询师协会的建议
J Genet Couns. 2014 Feb;23(1):5-15. doi: 10.1007/s10897-013-9636-9. Epub 2013 Sep 7.
7
Genetic Counseling for Fragile X Syndrome: Recommendations of the National Society of Genetic Counselors.脆性X综合征的遗传咨询:美国国家遗传咨询师协会的建议
J Genet Couns. 2000 Aug;9(4):303-25. doi: 10.1023/A:1009454112907.
8
Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors.遗传咨询实践中的囊性纤维化产前筛查:美国国家遗传咨询师协会的建议
J Genet Couns. 2005 Feb;14(1):1-15. doi: 10.1007/s10897-005-1496-5.
9
Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors.遗传咨询实践中的1型神经纤维瘤病:美国国家遗传咨询师协会的建议
J Genet Couns. 2007 Aug;16(4):387-407. doi: 10.1007/s10897-007-9101-8. Epub 2007 Jul 17.
10
Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors.遗传咨询实践中的法布里病:美国国家遗传咨询师协会的建议
J Genet Couns. 2002 Apr;11(2):121-46. doi: 10.1023/a:1014545521753.

引用本文的文献

1
Implementing a chatbot to promote hereditary breast & ovarian cancer genetic screening in women's health: identifying barriers and facilitators to screening adoption.实施聊天机器人以促进女性健康领域的遗传性乳腺癌和卵巢癌基因筛查:识别筛查采用的障碍和促进因素。
BMC Public Health. 2025 Jul 19;25(1):2516. doi: 10.1186/s12889-025-23488-4.
2
Lynch syndrome and colorectal cancer: A review of current perspectives in molecular genetics and clinical strategies.林奇综合征与结直肠癌:分子遗传学与临床策略的当前观点综述
Oncol Res. 2025 Jun 26;33(7):1531-1545. doi: 10.32604/or.2025.063951. eCollection 2025.
3
Identification of genomic variants associated with colorectal cancer heredity in indigenous populations of the Amazon.

本文引用的文献

1
Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.林奇综合征家系评估中的遗传咨询考量——综述
J Genet Couns. 2011 Feb;20(1):5-19. doi: 10.1007/s10897-010-9325-x. Epub 2010 Oct 8.
2
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.BRCA1 或 BRCA2 基因突变携带者的降低风险手术与癌症风险和死亡率的关联。
JAMA. 2010 Sep 1;304(9):967-75. doi: 10.1001/jama.2010.1237.
3
Exploring hereditary cancer among dying cancer patients--a cross-sectional study of hereditary risk and perceived awareness of DNA testing and banking.
亚马逊地区原住民中与结直肠癌遗传相关的基因组变异的鉴定。
Sci Rep. 2025 Apr 26;15(1):14616. doi: 10.1038/s41598-025-87401-0.
4
Understanding Genetic Screening: Harnessing Health Information to Prevent Disease Risks.了解基因筛查:利用健康信息预防疾病风险。
Int J Med Sci. 2025 Jan 21;22(4):903-919. doi: 10.7150/ijms.101219. eCollection 2025.
5
Assessing and attending to psychosocial concerns in genetic counseling: Proposing the BATHE method.评估并关注遗传咨询中的心理社会问题:提出BATHE方法。
J Genet Couns. 2025 Jun;34(3):e1998. doi: 10.1002/jgc4.1998. Epub 2024 Nov 13.
6
Expanding access to genetic testing for pancreatic cancer.扩大胰腺癌基因检测的可及性。
Fam Cancer. 2024 Aug;23(3):247-254. doi: 10.1007/s10689-024-00389-w. Epub 2024 May 11.
7
Advancing GCT Management: A Review of miR-371a-3p and Other miRNAs in Comparison to Traditional Serum Tumor Markers.进展期生殖细胞肿瘤管理:与传统血清肿瘤标志物相比,miR-371a-3p及其他微小RNA的综述
Cancers (Basel). 2024 Mar 31;16(7):1379. doi: 10.3390/cancers16071379.
8
The history of families at-risk for hereditary breast and ovarian cancer: what are the impacts of genetic counseling and testing?遗传性乳腺癌和卵巢癌高危家族的病史:遗传咨询与检测的影响有哪些?
Front Psychol. 2024 Mar 4;15:1306388. doi: 10.3389/fpsyg.2024.1306388. eCollection 2024.
9
Genetic counselors' and community clinicians' implementation and perceived barriers to informed consent during pre-test counseling for hereditary cancer risk.遗传咨询师和社区临床医生在遗传性癌症风险检测前咨询过程中实施知情同意的情况及感知到的障碍。
J Genet Couns. 2025 Feb;34(1):e1887. doi: 10.1002/jgc4.1887. Epub 2024 Mar 13.
10
Barriers and facilitators to the implementation of family cancer history collection tools in oncology clinical practices.在肿瘤临床实践中实施癌症家族史收集工具的障碍和促进因素。
J Am Med Inform Assoc. 2024 Feb 16;31(3):631-639. doi: 10.1093/jamia/ocad243.
探索临终癌症患者中的遗传性癌症——一项关于遗传风险以及对DNA检测和储存的认知的横断面研究
J Genet Couns. 2010 Oct;19(5):497-525. doi: 10.1007/s10897-010-9308-y. Epub 2010 Aug 3.
4
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.奥拉帕利在携带 BRCA1 或 BRCA2 突变的复发性卵巢癌患者中的疗效:一项概念验证试验。
Lancet. 2010 Jul 24;376(9737):245-51. doi: 10.1016/S0140-6736(10)60893-8. Epub 2010 Jul 6.
5
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.奥拉帕利治疗携带 BRCA1 或 BRCA2 突变的晚期乳腺癌患者的疗效:一项概念验证试验。
Lancet. 2010 Jul 24;376(9737):235-44. doi: 10.1016/S0140-6736(10)60892-6. Epub 2010 Jul 6.
6
Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study.预测 BRCA1 和 BRCA2 基因突变携带者:Penn II 模型与先前研究的比较。
Fam Cancer. 2010 Dec;9(4):495-502. doi: 10.1007/s10689-010-9348-3.
7
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.错配修复缺陷作为氟尿嘧啶为基础的辅助治疗结肠癌无效的预测标志物。
J Clin Oncol. 2010 Jul 10;28(20):3219-26. doi: 10.1200/JCO.2009.27.1825. Epub 2010 May 24.
8
Assessing women at high risk of breast cancer: a review of risk assessment models.评估高乳腺癌风险女性:风险评估模型回顾。
J Natl Cancer Inst. 2010 May 19;102(10):680-91. doi: 10.1093/jnci/djq088. Epub 2010 Apr 28.
9
What facilitates or impedes family communication following genetic testing for cancer risk? A systematic review and meta-synthesis of primary qualitative research.癌症风险基因检测后,哪些因素促进或阻碍了家庭沟通?一项关于原发性定性研究的系统评价和元综合分析。
J Genet Couns. 2010 Aug;19(4):330-42. doi: 10.1007/s10897-010-9296-y. Epub 2010 Apr 9.
10
Assessment of clinical practices among cancer genetic counselors.癌症遗传咨询师临床实践评估。
Fam Cancer. 2010 Sep;9(3):459-68. doi: 10.1007/s10689-010-9326-9.